Iovance Biotherapeutics Reports Third Quarter and September Year-to-Date 2019 Financial Results

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/7/2026

1. HUVR:IN
2. PANW
3. CL
4. SNDK
5. TAP
6. DELL
7. ROIV
8. ANET
9. NKE
10. BE

Go back to Iovance Biotherapeutics Reports Third Quarter and September Year-to-Date 2019 Financial Results

Iovance Biotherapeutics (IOVA) Misses Q3 EPS by 1c

November 4, 2019 4:02 PM EST

Iovance Biotherapeutics (NASDAQ: IOVA) reported Q3 EPS of ($0.40), $0.01 worse than the analyst estimate of ($0.39).

We continue making great progress in developing tumor infiltrating lymphocyte (TIL) therapy, which could become the first approved cell therapy product for solid tumor indications, commented Maria Fardis, Ph.D.,... More